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TGF-b1 is a regulatory cytokine that has an important
role in controlling T cell differentiation. T cell-
produced TGF-b1 acts on T cells to promote Th17
cell differentiation and the development of experi-
mental autoimmune encephalomyelitis (EAE).
However, the exact TGF-b1-producing T cell subset
required for Th17 cell generation and its cellular
mechanism of action remain unknown. Here we
showed that deletion of the Tgfb1 gene from acti-
vated T cells and Treg cells, but not Treg cells alone,
abrogated Th17 cell differentiation, resulting in
almost complete protection from EAE. Furthermore,
differentiation of T cells both in vitro and in vivo
demonstrated that TGF-b1 was highly expressed
by Th17 cells and acted in a predominantly autocrine
manner to maintain Th17 cells in vivo. These findings
reveal an essential role for activated T cell-produced
TGF-b1 in promoting the differentiation of Th17 cells
and controlling inflammatory diseases.INTRODUCTION
CD4+ T helper (Th) cells are central regulators of adaptive
immune responses. Upon recognition of their cognate antigen
in the context of associated environmental cues, naive CD4+
T cells differentiate into Th1, Th2, and Th17 cells characterized
by the secretion of signature cytokines IFN-g, IL-4, and IL-17,
respectively (Korn et al., 2009; Zhu et al., 2010). The various
subsets of Th cells orchestrate host defense responses against
a wide range of pathogens. However, deregulated Th cell
responses result in immunopathology and the development of
autoimmune diseases and atopic syndromes (Gutcher and
Becher, 2007; Veldhoen, 2009).
How Th cell differentiation is initiated and regulated is an area
of active research. Cytokines that activate the STAT family of
transcription factors have been shown to play crucial roles in
the induction and maintenance of Th cell differentiation (Zhu
et al., 2010). Activation of the transcription factors STAT1 and
STAT4 by IFN-g and IL-12, respectively, instructs naive T cells
to develop into Th1 cells. Subsequently, IFN-g produced by396 Immunity 34, 396–408, March 25, 2011 ª2011 Elsevier Inc.Th1 cells functions via an autocrine route to stabilize Th1 cell
differentiation. IL-4 plays an analogous role in the initiation and
stabilization of Th2 cell differentiation through the activation of
STAT6. Th17 cell development is dependent on STAT3. The
two STAT3 activators IL-6 and IL-23 are produced by innate
immune cells and have critical functions in promoting the early
and late stages of Th17 cell differentiation. Intriguingly, another
STAT3 activator, IL-21, is preferentially expressed by Th17 cells
and is involved in the maintenance of Th17 cell differentiation
(Korn et al., 2007; Nurieva et al., 2007; Wei et al., 2007). Thus,
it appears that all three Th cell types produce unique sets of
STAT-activating cytokines to maintain the heritable develop-
mental programs of their respective lineages.
Transforming growth factor-b1 (TGF-b1) is a regulatory
cytokine with a pivotal role in controlling T cell homeostasis
and differentiation (Li and Flavell, 2008). Mice with complete
TGF-b1 deficiency develop a T cell-dependent multifocal inflam-
matory disease that leads to their early demise at 3–4 weeks of
age (Kulkarni et al., 1993; Shull et al., 1992). The importance of
TGF-b signaling in T cells has been shown by means of trans-
genic mice with a T cell-specific deletion of TGF-b-receptor II
(TGF-bRII) or expression of a dominant-negative TGF-bRII (Gor-
elik and Flavell, 2000; Li et al., 2006a; Marie et al., 2006). Similar
to complete TGF-b1 deficiency, mice with abrogated TGF-b1
signaling in T cells succumb to severe inflammatory disease
associated with spontaneous T cell activation and Th1 and Th2
cell differentiation. Contrasting with its role in inhibiting Th1
and Th2 cell differentiation, TGF-b signaling has been shown to
promote the generation of Th17 cells. In the presence of IL-6,
TGF-b1 induces the development of Th17 cells that have been
shown to drive autoimmune diseases such as experimental
autoimmune encephalomyelitis (EAE) (Bettelli et al., 2006; Langr-
ish et al., 2005; Mangan et al., 2006; Veldhoen et al., 2006a). As
such, diminished TGF-b signaling in T cells prevents Th17 cell
generation and results in resistance to EAE (Veldhoen et al.,
2006b).
TGF-b1 is produced by multiple cell types and requires intra-
cellular processing by the proprotein convertase furin for matu-
ration (Dubois et al., 2001). Recent studies in mice with T cell-
specific deletion of the Tgfb1 or the Furin gene revealed that
T cells are the essential source of TGF-b1 required for controlling
T cell tolerance and differentiation (Li et al., 2007; Pesu et al.,
2008). In the absence of T cell-produced TGF-b1, conventional
T cells differentiate into Th1 and Th2 cells, whereas CD4+Foxp3+
regulatory T (Treg) cells undergo high rates of proliferation. As
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pathology in multiple organs and succumb to Th1 cell-mediated
colitis. In addition, these mice are resistant to EAE, which is
associated with abrogated Th17 cells in the central nervous
system. These findings are in line with the observation that local
but not systemic administration of neutralizing TGF-b1 antibody
inhibits Th17 cell generation, implicating autocrine or paracrine
sources of TGF-b1 as key for regulating Th17 cell development
(Veldhoen et al., 2006b). However, the exact T cell source or
sources of TGF-b1 and the cellular mechanisms required for its
regulation of Th17 cell differentiation remain unknown. Although
early studies have shown that activated T cells can produce
TGF-b1 (Kehrl et al., 1986), it has more recently been demon-
strated that Treg cells induce the development of Th17 cells in
the presence of lipopolysacharride (LPS) in vitro (Veldhoen
et al., 2006a). Furthermore, in models of graft-versus-host
disease, the cotransfer of Treg cells enhances IL-17 production
by T cells (Lohr et al., 2006; Vokaer et al., 2010). These data point
toward a role for Treg cell-produced TGF-b1 in inhibiting Th1 cell
differentiation and promoting Th17 cell development and, more-
over, they suggest a paracrinemechanism of TGF-b1 signaling in
regulating T cell tolerance and Th17 cell differentiation.
In this study, we specifically deleted the Tgfb1 gene in acti-
vated T cells and Treg cells or in Treg cells alone to determine
the exact T cell source of TGF-b1 for regulating T cell tolerance
and differentiation. We found that abrogation of TGF-b1 in acti-
vated T cells and Treg cells, but not Treg cells alone, protected
mice from EAE associated with compromised encephalitogenic
Th17 cell differentiation. Analysis of Th cell subsets demon-
strated that Th17 cells were the main producers of TGF-b1 both
in vitro and in vivo. Furthermore, immunization of mixed bone
marrow-chimeric mice demonstrated that TGF-b1 acted
predominantly in anautocrinemanner topromoteTh17cell differ-
entiation in vivo. These results indicate that similar to the STAT3-
activating cytokine IL-21, TGF-b1 produced by Th17 cells is
necessary for stabilizing the commitment of the Th17 cell lineage.
RESULTS
TGF-b1-GFP Knockin Mice Reveal TGF-b1 Expression
in Thymic and Peripheral T Cells
To study TGF-b1 expression in vivo, we have generated amouse
strain in which the coding region of green fluorescent protein
(GFP) is inserted into the first exon of the Tgfb1 gene (Figure S1
available online) thereby generating a Tgfb1-null allele. Mice
hemizygous for themutant allele (hereafter referred toasTGF-b1-
GFP mice) were devoid of the immunopathology associated
with TGF-b1 deficiency and allowed the expression of TGF-b1
to be characterized by GFP expression. To determine the
expression of TGF-b1 in the T cell compartment, we further
crossed TGF-b1-GFPmicewith Foxp3-RFPmice inwhich alleles
of red fluorescent protein (RFP) are contained in the Foxp3 locus
(Wan and Flavell, 2005). Examination of immature CD4+CD8+
and mature TCR-bhiCD4+ and TCR-bhiCD8+ thymocytes by
flow cytometry demonstrated that GFP expression was negli-
gible in CD4+CD8+ cells but was upregulated upon maturation
of thymocytes to conventional CD4+Foxp3 and CD8+ T cells
(Figure 1A). Furthermore, GFP expression was particularly
enhanced in thymic CD4+Foxp3+ Treg cells (Figure 1A). Charac-terization of naive peripheral T cells showed increased GFP
expression in comparison to thymic T cells (Figure 1B). The
mean fluorescent intensity was similar in peripheral CD4+Foxp3
(MFI = 13.9) and CD8+ (MFI = 13.5) T cells and moderately
increased in Treg cells (MFI = 18.6). To confirm that GFP expres-
sion reflects TGF-b1 upregulation, we tested the amount of
TGF-b1 protein in the supernatant of the T cell subsets. TGF-b1
was produced by all three subsets but was consistently higher
in the supernatant of stimulated Treg cells (Figure 1C). Thus,
TGF-b1-GFP mice can be used as a tool to analyze cellular
TGF-b1 expression and TGF-b1 is expressed by all T cell
subsets, especially Treg cells.TGF-b1 Deletion from OX40-Positive T Cells Results
in Treg Cell Expansion and Th1 Cell Differentiation
TGF-b1 produced by T cells is essential for controlling T cell
tolerance and differentiation (Li et al., 2007). Because the
Tgfb1f/n Cd4-cre mice used in that previous study deleted the
Tgfb1 gene from both CD4+ and CD8+ T cells, we investigated
the precise TGF-b1-producing T cell subset that is required for
the regulation of T cell responses. To do so, we used mice with
floxed/null alleles (hereafter called Tgfb1f/n mice) that express
a Tgfb1 floxed allele and a TGF-b1-GFP knockin allele as previ-
ously reported (Li et al., 2007). We crossed these mice with
Tnfrsf4 (encoding OX40)-cre mice that contain the gene that
encodes Cre recombinase driven by the Tnfrsf4 promoter, which
results in its expression in both the Treg and activated CD4+
T cell compartments (Klinger et al., 2009). To confirm recombina-
tion of the Tgfb1 locus in Tnfrsf4-cre mice, we analyzed yellow
fluorescent protein (YFP)-positive and -negative cells from
Tnfrsf4-cre-YFP mice that carry a Cre-dependent YFP reporter
allele. As expected, YFP expression was present in more than
88%of Treg cells and 65%of activated CD4+ T cells of the lymph
nodes (LNs), whereas it was expressed by less than 8% of naive
CD4+ T cells and no more than 5% of naive and activated CD8+
T cells (Figure S2A). Deletion of the loxP-flanked Tgfb1 allele was
detected in the majority of Treg cells and activated CD4+ T cells,
whereas its deletion in naive T cells was partial (Figure S2B).
Thus Tnfrsf4-cre induces efficient ablation of the Tgfb1 allele in
Treg cells as well as in activated CD4+ T cells.
In the absence of T cell-produced TGF-b1, mice develop
a severe wasting disease that is characterized by heavy mono-
nuclear infiltrates in the colon as well as in the liver and lungs
(Li et al., 2007). Compared to Tgfb1f/n Cd4-cre mice reported
earlier, milder signs of wasting disease and colitis were observed
in Tgfb1f/n Tnfrsf4-cremice beginning at around 5months of age.
Consistent with this phenotype, histological examination
demonstrated mononuclear cell infiltrates in the mucosal lamina
propria of the colon in these mice (Figure 2A, left). Quantification
of these sections confirmed that Tgfb1f/n Tnfrsf4-cremice devel-
oped mild inflammation with slight epithelial hyperplasia and
increased numbers of leukocytes in the mucosa (Figure 2B).
We also observed small foci of infiltrating mononuclear cells in
the liver parenchyma (Figure 2A, middle) and lungs (Figure 2A,
right) of Tgfb1f/n Tnfrsf4-cremice, which were absent in Tgfb1f/n
littermates. Therefore, TGF-b1 produced by Treg and/or acti-
vated CD4+ T cells is required to protect mice from the develop-
ment of an inflammatory disorder.Immunity 34, 396–408, March 25, 2011 ª2011 Elsevier Inc. 397
Figure 1. TGF-b1-GFP Knockin Mice Reveal Expression of TGF-b1 in Thymic and Peripheral T Cells
(A) GFP expression in CD4+CD8+ double-positive (DP), CD4+Foxp3, CD4+Foxp3+, and CD8+ thymocytes of TGF-b1-GFP Foxp3-RFP mice was determined by
flow cytometric analysis. GFP-negative WT mice were used as a control. Shown are representative results of three mice per group analyzed.
(B) GFP expression in peripheral lymph node CD4+Foxp3, CD4+Foxp3+, and CD8+ T cells of TGF-b1-GFP Foxp3-RFP mice was analyzed by flow cytometric
analysis. These results are representative of three mice per group.
(C) CD4+Foxp3, CD4+Foxp3+, and CD8+ T cells purified from Foxp3-RFP mice were stimulated with CD3 and CD28 antibodies in the presence of IL-2 for 24 hr.
TGF-b1 amounts in culture supernatant were determined by ELISA.
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essential for the inhibition of T cell activation and their differenti-
ation into Th1 and Th2 cells (Li et al., 2007). Unlike in Tgfb1f/n
Cd4-cre mice, there was only marginally enhanced activation
and differentiation of T cells in the peripheral lymph nodes
(pLNs), spleen, and mesenteric lymph nodes (mLNs) of Tgfb1f/n
Tnfrsf4-cre mice (Figure S2C and data not shown). We have
also reported that T cell-produced TGF-b1 is required to control
the proliferation of Treg cells in the peripheral lymphoid organs
(Li et al., 2007). Analysis of pLNs and mLNs showed that, in
comparison to their Tgfb1f/n littermates, there was a higher
frequency of CD4+Foxp3+ Treg cells in Tgfb1f/n Tnfrsf4-cre
mice (Figures 2C and 2D), which is similar to that previously
observed in Tgfb1f/n Cd4-cre mice (Li et al., 2007). Increased
numbers of Treg as well as CD4+Foxp3 and CD8+ T cells
were also detected in the mLNs of Tgfb1f/n Tnfrsf4-cre mice in
comparison to control mice (Figure 2E). These findings reveal
that in the microenvironment of the mLNs, which are the draining
LNs of the intestine, TGF-b1 deletion in OX40-postive cells
results in the expansion of Treg and conventional T cells.
Our data indicate that the absence of TGF-b1 from activated
CD4+ T cells and Treg cells did not substantially affect T cell acti-
vation in LNs and spleen. We therefore decided to examine the398 Immunity 34, 396–408, March 25, 2011 ª2011 Elsevier Inc.differentiation of T cells in the gut where there is an increased
frequency of activated T cells (Ivanov et al., 2008), thereby
allowing the analysis of TGF-b1 deletion in both the Treg and
effector CD4+ T cell compartments. Intraepithelial lymphocytes
(IELs) from the small intestine showed a significantly higher
frequency of IFN-g-producing Th1 cells and a trend toward
reduced percentage of IL-17-expressing Th17 cells in Tgfb1f/n
Tnfrsf4-cre mice compared to Tgfb1f/n controls (Figure 2F).
Collectively, these findings reveal that TGF-b1 produced by
Treg cells and/or activated CD4+ T cells is required to inhibit
Treg cell expansion and is essential for inhibiting Th1 cell differ-
entiation in the gut.
TGF-b1 Abrogation from OX40-Positive Cells
Compromises Th17 Cell Generation
Together with IL-6, TGF-b1 is required for the de novo differen-
tiation of Th17 effector cells that are implicated in autoimmune
pathogenesis (Bettelli et al., 2006; Mangan et al., 2006; Veldhoen
et al., 2006a). Our previous studies in Tgfb1f/nCd4-cremice have
demonstrated that T cells are the critical source of TGF-b1 for the
generation of encephalitogenic Th17 cells, and consequently
disease development, during MOG35-55-induced EAE (Li et al.,
2007). We therefore wanted to determine whether TGF-b1
Immunity
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cell differentiation and disease development in the context of
EAE. We first immunized Tnfrsf4-cre-YFP mice in order to
analyze the cellular specificity of recombination of the floxed
Tgfb1 gene during MOG35-55-induced EAE. Flow cytometry of
infiltrating cells from the spinal cord of diseased mice demon-
strated that YFP is expressed in most CD4+ T cells (more than
80%) and a minor population of CD8+ T cells (about 20%) (Fig-
ure S2D). We immunized Tgfb1f/n Tnfrsf4-cre mice and their
WT littermates with MOG35-55 in complete Freund’s adjuvant
(CFA), which showed that, similar to Tgfb1f/n Cd4-cre mice,
Tgfb1f/n Tnfrsf4-cre mice were almost completely resistant to
the development of EAE (Figure 3A). Five out of seven mice did
not demonstrate any symptoms associated with EAE whereas
the remaining two mice developed EAE with a clinical onset
and severity almost identical to that of Tgfb1f/n mice. At day 21
postimmunization, we isolated the infiltrating leukocytes from
the CNS of immunizedmice and performed intracellular cytokine
staining to determine whether EAE resistance in Tgfb1f/n Tnfrsf4-
cremice is associated with reduced frequency of Th17 cells. As
expected, IL-17- and IFN-g-producing CD4+ T cells were found
in the CNS of Tgfb1f/n mice with EAE (Figure 3B). In contrast,
there was a significant decrease in the presence of IL-17-
producing CD4+ T cells in Tgfb1f/n Tnfrsf4-cre mice as well as
a small, but insignificant, increase in the percentage of Th1 cells
(Figures 3B and 3C). Interestingly, in Tgfb1f/n Tnfrsf4-cre mice
that had developed EAE symptoms, infiltrating CD4+ T cells
mostly produced large amounts of IFN-g whereas the
percentage of Th17 cells present was minimal (Figure 3B, right).
This is similar to what we have previously demonstrated in
Tgfb1f/n Cd4-cre mice that develop mild EAE (Li et al., 2007).
Taken together, these data show that the production of TGF-
b1 from Treg cells and/or effector CD4+ T cells is indispensable
for the differentiation of Th17 cells and the induction of EAE.
Treg Cell-Produced TGF-b1 Is Essential for the
Inhibition of Treg Cell Expansion
To further narrow down the T cell source of TGF-b1 that is
required for controlling T cell homeostasis and differentiation,
we crossed Tgfb1f/n mice with Foxp3-cre mice to delete
TGF-b1 in Treg cells. Foxp3-cremice have been shown to delete
floxed genes efficiently and specifically in Treg cells (Rubtsov
et al., 2008). With Foxp3-cre-YFP mice, we confirmed the
recombination of the Tgfb1 allele in almost all CD25+CD4+
Treg cells in comparison to minor deletion in CD25CD4+
T cells (Figure S2E).
In contrast to the wasting disease that developed in Tgfb1f/n
Tnfrsf4-cre mice (Figure 2A), Tgfb1f/n Foxp3-cre mice remained
healthy and showed no signs of inflammation even at the age
of 9 months (data not shown). To determine the impact of Treg
cell-specific TGF-b1 deletion on T cell homeostasis, we analyzed
the T cell compartment in the peripheral lymphoid organs.
Similar to the results in Tgfb1f/n Tnfrsf4-cre mice (Figure 2C),
Tgfb1f/n Foxp3-cre mice had significantly increased frequencies
of CD4+Foxp3+ Treg cells in the pLNs and mLNs but not in the
spleen (Figures 4A and 4B). Furthermore, there was a more
than 2-fold increase in the number of mesenteric Treg cells in
Tgfb1f/n Foxp3-cre mice (Figure 4C). In contrast to Tgfb1f/n
Tnfrsf4-cre mice, however, there was no increase in CD4+Foxp3 and CD8+ T cell numbers in the mLNs of Tgfb1f/n
Foxp3-cre mice (Figure 4C). Analysis of T cells in the peripheral
lymphoid organs of Tgfb1f/n Foxp3-cre mice showed no
spontaneous activation and differentiation of T cells (data not
shown). These results demonstrate that TGF-b1 produced by
Treg cells alone is specifically required for inhibiting Treg cell
proliferation.
Treg cells are highly abundant in gut-associated tissues (Iva-
nov et al., 2008). Previous studies have demonstrated that the
TGF-b pathway is required for Treg cell inhibition of inflammation
in a transfer model of colitis (Fahle´n et al., 2005; Li et al., 2007;
Powrie et al., 1996). By using TGF-b1-deficient Treg cells, we
could show that Treg cell-produced TGF-b1 contributes to the
inhibition of Th1 cell differentiation and the ensuing development
of colitis (Li et al., 2007). Because TGF-b1 produced by activated
CD4+ T cells and Treg cells was necessary to prevent sponta-
neous Th1 cell differentiation in the intestine (Figure 2E), we
wondered whether this inhibition depends solely on Treg cell-
produced TGF-b1. There was no difference in the frequency of
IFN-g-producing Th1 cells or IL-17-producing Th17 cells in the
IELs of Tgfb1f/n Foxp3-cre mice in comparison to Tgfb1f/n mice
(Figure 4D). Therefore Treg cell-produced TGF-b1 is dispensable
for inhibiting the development of Th1 cells in the peripheral
immune system as well as in the intestinal mucosa in the steady
state.
Treg Cell-Produced TGF-b1 Is Dispensable for Effector
Th17 Cell Differentiation
Treg cells have been shown to promote Th17 cell differentiation
both in vitro and in models of systemic autoimmune disease
and graft-versus-host disease (Lohr et al., 2006; Veldhoen
et al., 2006a; Vokaer et al., 2010). Absence of TGF-b1 production
by OX40-positive cells abrogated the generation of Th17 cells
duringMOG35-55-induced EAE (Figures 3B and 3C).We therefore
sought to determine the role of TGF-b1 produced by Treg cells
alone in promoting Th17 cell differentiation during EAE. Immuni-
zation of Tgfb1f/n Foxp3-cre mice with MOG35-55 demonstrated
that they were susceptible to EAE development and furthermore
they showed a clinical onset and severity that was similar to that
of Tgfb1f/n littermates (Figure 5A). In accordance with their
susceptibility to disease, there was no defect in the ability
of Tgfb1f/n Foxp3-cre mice to generate IL-17-producing CD4+
T cells (Figure 5B) and indeed the mean percentages of IFN-g-
and IL-17-producing T cells were comparable to those of
Tgfb1f/n mice (Figure 5C). We have previously shown through
fate-mapping experiments that a small fraction of Th17 cells in
the intestine are derived from T cells that have expressed
Foxp3 at some point during their development (Zhou et al.,
2008). To investigate TGF-b1 deletion in Th17 cells of Tgfb1f/n
Foxp3-cre mice, we analyzed recombination of the Tgfb1 allele
in both in vitro differentiated Th17 cells and CCR6+CD4+ T cells
that were enriched for Th17 cells (see below) isolated from the
CNS of Tgfb1f/n Foxp3-cre mice with EAE. There was minimal
deletion of Tgfb1 allele in Th17 cells, as compared to Treg cells,
from Tgfb1f/n Foxp3-cremice both in vitro and in vivo (Figure S3),
supporting specific Cre expression in Treg cells in these mice.
Altogether these data indicate that TGF-b1 produced by
Treg cells is not essential for Th17 cell differentiation in the EAE
model.Immunity 34, 396–408, March 25, 2011 ª2011 Elsevier Inc. 399
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Figure 2. TGF-b1 Deletion from OX40-Positive T Cells Results in Treg Cell Expansion and Th1 Cell Differentiation
(A) Hematoxylin and eosin staining of colon, liver, and lung sections (original magnification, 203) of Tgfb1f/n and Tgfb1f/n Tnfrsf4-cre mice at 5 months of age.
These are representative results of five mice per group analyzed.
(B) Quantification of histological grading of colitis in Tgfb1f/n and Tgfb1f/n Tnfrsf4-cremice at 5 months of age. These are results of five mice per group analyzed.
The p values between the two groups are shown. Asterisk indicates significant difference.
(C and D) Flow cytometric analysis of Foxp3 expression in peripheral lymph node, spleen, and mesenteric lymph node CD4+ T cells from Tgfb1f/n and Tgfb1f/n
Tnfrsf4-cre mice.
(C) Representative plots of peripheral lymph node (n = 5–6), spleen (n = 3–4), and mesenteric lymph node (n = 5–6) are presented.
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Figure 3. TGF-b1 Abrogation from OX40-
Positive T Cells Compromises Th17 Cell
Generation
(A) EAE disease course in Tgfb1f/n and Tgfb1f/n
Tnfrsf4-cremice (n = 7). Disease scores are plotted
as mean ± SEM. Asterisk indicates significant
difference.
(B and C) Cytokine production by CD4+ T cells
isolated from the CNS day 21 after disease
induction. The cells were stimulated with PMA and
ionomycin for 4 hr and were analyzed for IFN-g and
IL-17 expression. Five out of seven Tgfb1f/n
Tnfrsf4-cre mice did not develop any clinical sign
of disease (score 0), whereas the remaining two
developed disease similar to Tgfb1f/n littermates
(final score 2). The representative plots of diseased
and healthy Tgfb1f/n and Tgfb1f/n Tnfrsf4-cre mice
are shown in (B). The frequencies of IFN-g- and
IL-17-producing CD4+ T cells are shown in (C). The
p values of percentiles of cells producing IFN-g or
IL-17 between the two groups are indicated.
Asterisk indicates significant difference.
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Autocrine TGF-b1 Promotes Th17 Cell DifferentiationTGF-b1 Is Highly Expressed by Effector Th17 Cells
Given that TGF-b1 secretion by activated CD4+ T cells and Treg
cells, but not Treg cells alone, is an absolute requirement for
Th17 cell regulation in the EAE model, we wanted to determine
the expression of TGF-b1 by different effector CD4+ T cell
subsets. To do so, we analyzed the expression of GFP by naive
CD4+ T cells from hemizygous TGF-b1-GFP knockin mice differ-
entiated toward Th1, Th2, and Th17 cell subsets in vitro for
3 days. GFP was upregulated to the same extent by Th1 and(D) Percentage of Foxp3-expressing Treg cells in the two groups is indicated. The p values between the tw
difference.
(E) Numbers of CD4+Foxp3, CD4+Foxp3+, and CD8+ T cells in themesenteric lymph nodes of Tgfb1f/n and Tg
numbers between the two groups of mice are indicated. Asterisk indicates significant difference.
(F) Cytokine production of intraepithelial CD4+ T cells of the gut of Tgfb1f/n and Tgfb1f/n Tnfrsf4-cremice. Intr
and ionomycin for 4 hr and were analyzed for IFN-g and IL-17 expression. These are representative profiles of
cytokine amounts between the two groups are indicated. Asterisk indicates significant difference.
Immunity 34, 396–40Th2 cell subsets but was most highly up-
regulated in Th17 cells (Figure 6A). We
next confirmed the expression of TGF-
b1 at the protein level by restimulating
differentiated CD4+ T cells with CD3 anti-
body in serum-free medium for 24 hr and
performing TGF-b1 ELISA of the superna-
tant. TGF-b1 was produced by all helper
T cell subsets, but there were significantly
higher levels of TGF-b1 in the supernatant
of effector Th17 cells (Figure 6B). There-
fore, under in vitro T cell differentiation
conditions, effector Th17 cells are the
major producers of TGF-b1.
To determine whether TGF-b1 is
predominantly produced by Th17 cells
in vivo, we wished to analyze the expres-
sion of TGF-b1 in IL-17-positive and
-negative cells. TGF-b1-GFP knockinmice were immunized with MOG35-55 in CFA and the CNS-infil-
trating cells were isolated upon disease onset. In order to identify
infiltrating Th17 cells, we assessed the T cells for expression of
the chemokine receptor CCR6, which is preferentially expressed
on differentiated Th17 cells (Reboldi et al., 2009; Yamazaki et al.,
2008). We confirmed that CCR6-positive cells expressed high
amounts of IL-17 whereas CCR6-negative cells contained
a mix of both Th1 and Th17 cells although they were predomi-
nantly IFN-g producers (Figure 6C). Gating on CCR6-positiveo groups are shown. Asterisk indicates significant
fb1f/n Tnfrsf4-cremice (n = 5–6). The p values of cell
aepithelial lymphocytes were stimulated with PMA
five to six mice per group analyzed. The p values of
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Figure 4. Treg Cell-Produced TGF-b1 Is Essential for the Inhibition of Treg Cell Expansion
(A and B) Flow cytometric analysis of Foxp3 expression in CD4+ T cells from peripheral lymph nodes, spleen, andmesenteric lymph nodes of Tgfb1f/n and Tgfb1f/n
Foxp3-cre mice. Representative results are presented in (A) and percentage of Treg cells in peripheral lymph nodes, spleen, and mesenteric lymph nodes are
shown in (B). The p values of Treg cell numbers between the two groups are indicated. Asterisk indicates significant difference.
(C) Number of CD4+Foxp3, CD4+Foxp3+, and CD8+ T cells in themesenteric lymph nodes of Tgfb1f/n and Tgfb1f/n Foxp3-cremice (n = 7–10). The p values of cell
numbers between the two groups of mice are indicated. Asterisk indicates significant difference.
(D) Cytokine production by intraepithelial CD4+ T cells of the small intestine of Tgfb1f/n and Tgfb1f/n Foxp3-cremice. Intraepithelial lymphocytes were stimulated
with PMA and ionomycin for 4 hr and were analyzed for IFN-g and IL-17 expression. These are representative profiles of five mice per group analyzed. The p
values of cytokine amounts between the two groups are indicated.
Immunity
Autocrine TGF-b1 Promotes Th17 Cell Differentiationand CCR6-negative CD4+ T cells demonstrated that there was
an almost 2-fold increase in the mean fluorescence intensity of
GFP expression in CCR6-positive Th17 cells versus CCR6-
negative T cells (Figure 6C). These observations demonstrate
that TGF-b1 is expressed by all effector Th cell subsets;
however, it is especially upregulated by differentiated Th17 cells
both in vitro and in vivo.
T Cell-Produced TGF-b1 Acts in an Autocrine Manner
to Promote Th17 Cell Differentiation
Because TGF-b1 was highly produced by Th17 cells, we
wanted to assess whether T cell-produced TGF-b1 functions402 Immunity 34, 396–408, March 25, 2011 ª2011 Elsevier Inc.in an autocrine or paracrine manner to control Th17 cell differ-
entiation. To test this hypothesis, we generated mixed bone
marrow-chimeric mice. Rag1/ recipient mice were sublethally
irradiated and reconstituted with a 1:1 mix of WT and Tgfb1f/n
Cd4-cre bone marrow on the CD45.1 and CD45.2 congenic
backgrounds, respectively. After 6 weeks, mice were
immunized with MOG35-55 to induce EAE. At the peak of
disease, CNS-infiltrating CD4+ T cells were isolated and the
frequencies of Th17 and Th1 cells in the CD45.1 and CD45.2
populations were tested by flow cytometry. As expected, WT
(CD45.1) CD4+ T cells had differentiated into both IL-17- and
IFN-g-expressing effector T cells (Figure 7A, left). In contrast,
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Figure 5. Treg Cell-Produced TGF-b1 Is Dispensable for Effector
Th17 Cell Differentiation
(A) EAE disease course in Tgfb1f/n and Tgfb1f/n Foxp3-cre (n = 7–9). Disease
scores are plotted as mean ± SEM.
(B and C) Cytokine production by CD4+ T cells isolated from the CNS day 21
after disease induction. The cells were stimulated with PMA and ionomycin for
4 hr and were analyzed for IFN-g and IL-17 expression. The representative
plots of diseased Tgfb1f/n and Tgfb1f/n Foxp3-cre mice with a final score of 2
are shown in (B). The frequency of IFN-g- and IL-17-producing CD4+ T cells are
shown in (C). The p values of percentiles of cells producing IFN-g or IL-17
between the two groups are indicated.
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Autocrine TGF-b1 Promotes Th17 Cell Differentiationthere was a substantial decrease in the frequency of Th17 cells
and a slight increase in Th1 cells among the Tgfb1f/n Cd4-cre
(CD45.2) CD4+ T cell population in the same mouse (Figure 7A,
right). This resulted in ratios of 2.44 and 0.7882 for WT:Tgfb1f/n
Cd4-cre Th17 and Th1 cells, respectively (Figure 7B). The
decreased frequency of IL-17-producing Tgfb1f/n Cd4-cre
CD4+ T cells suggests that T cell-produced TGF-b1 is required
to function predominantly in an autocrine manner to regulate
the maintenance of Th17 cells (Figure S4).DISCUSSION
TGF-b1 is a regulatory cytokine that is secreted by themajority of
cell types and has a critical role in controlling T cell differentiation(Li and Flavell, 2008; Li et al., 2006a; Marie et al., 2006). In this
report, we generated mice with TGF-b1 deletion in both acti-
vated CD4+ T cells and Treg cells or in Treg cells alone by
breeding floxed Tgfb1mice with Tnfrsf4-cre or Foxp3-cre trans-
genic mice, respectively. With these transgenic models, we
showed that TGF-b1 produced specifically by Treg cells is
essential for hindering expansion of peripheral Treg cells. In
addition, TGF-b1 deletion from activated CD4+ T cells and
Treg cells, but not Treg cells alone, abrogated the generation
of encephalitogenic Th17 cells during MOG35-55-induced EAE.
By using TGF-b1-GFP knockin mice and by generating BM
chimeric mice, we could show that TGF-b1 is highly upregulated
in effector Th17 cells and functions predominantly in an
autocrine loop to promote Th17 cell differentiation during auto-
immunity. These results uncover the precise cellular sources of
CD4+ T cell-produced TGF-b1 for controlling T cell differentiation
and provide the cellular mechanism required for maintaining the
commitment of the Th17 cell lineage.
There is much plasticity in the heritable development of Th17
cells, which results in the conversion of in vitro generated Th17
cells to Th1 cells when transferred to recipient mice (Bending
et al., 2009;Martin-Orozco et al., 2009; Zhou et al., 2009). Recent
data demonstrating the loss of IL-17 expression in differentiated
Th17 cells in the absence of TGF-b1 implicate a role for TGF-b1
in maintaining the differentiation of Th17 cells as well as inducing
their development (Lee et al., 2009; Lexberg et al., 2008; Zhu
et al., 2010). In this report, we were able to show, both in vitro
and in vivo, that TGF-b1 is highly upregulated by differentiated
Th17 cells. This is analogous to the upregulation of IFN-g and
IL-4 by Th1 and Th2 cells, respectively, which are the key
inducers as well as the major stabilizers of those corresponding
differentiation programs. The autocrine action of activated CD4+
T cell-produced TGF-b1 implicates a dual function for TGF-b1 in
inducing the development and maintaining the commitment of
Th17 cells. In contrast to other cytokines involved in effector
T cell maintenance, TGF-b1 does not signal through the STAT
pathway, making it a unique cytokine for the maintenance of
T cell differentiation.
The molecular mechanism of TGF-b1 signaling for polarization
of Th17 cells is still unclear. TGF-b1 is superfluous in T cells that
are deficient in Th1 and Th2 cell transcription factors, implying
that TGF-b1 promotes Th17 cell differentiation indirectly by in-
hibiting Th1 and/or Th2 cell differentiation (Das et al., 2009).
Despite the abrogation of Th17 cells in Tgfb1f/n Tnfrsf4-cre
mice upon EAE induction, we did not observe a marked increase
in Th1 cell generation. This suggests that there are alternative
molecular mechanisms controlling the initiation and mainte-
nance of Th17 cell differentiation by TGF-b1. In vitro, the pres-
ence of TGF-b1 and IL-6 is sufficient for the differentiation of
Th17 cells. During in vivo differentiation, a more complex
network of cytokines, including IL-23, IL-21, and IL-1b, act to
promote or maintain Th17 cell development in addition to
TGF-b1 and IL-6 (Chung et al., 2009; Korn et al., 2007, 2009;
Nurieva et al., 2007; Wei et al., 2007). It will therefore also be of
interest to identify the precise Th17 cell-inducing cytokines
responsible for the upregulation of TGF-b1 expression during
Th17 cell development.
Th17 cells are characterized by their production of the signa-
ture cytokines IL-17, IL-17F, and IL-22 (Harrington et al., 2005;Immunity 34, 396–408, March 25, 2011 ª2011 Elsevier Inc. 403
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Figure 6. TGF-b1 Is Highly Expressed by Effector Th17 Cells
(A) Naive CD4+ T cells from TGF-b1-GFP knockin mice were differentiated to Th1, Th2, and Th17 cells in vitro for 3 days and then analyzed for upregulation of GFP
expression by flow cytometry. These are representative results of three independent experiments.
(B) Naive CD4+ T cells fromC57BL/6mice were differentiated to Th1, Th2, and Th17 cells in vitro for 3 days and 23 106 cells were restimulated with CD3 antibody
for 24 hr. TGF-b1 amounts in the supernatants were determined by ELISA. A representative of three independent experiments is shown. The p values between the
groups are shown. Asterisk indicates significant difference.
(C) GFP expression in CCR6+ and CCR6CD4+ T cells isolated from the CNS of MOG35-55-immunized TGF-b1-GFP knockin mice. TGF-b1-GFP knockin mice
were immunized withMOG35-55 and infiltrating mononuclear cells were isolated from the CNS after disease onset and stimulated with PMA and ionomycin for 4 hr
to analyze IL-17 and IFN-g expression in CCR6+ and CCR6CD4+ T cells (left). Histogram shows GFP expression in TGF-b1-GFP knockin mice in comparison to
GFP-negative controls (right). Data are representative of three TGF-b1-GFP knockin mice analyzed.
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Autocrine TGF-b1 Promotes Th17 Cell DifferentiationKorn et al., 2009; Park et al., 2005; Veldhoen et al., 2006a). Our
data suggest that, in addition to these cytokines, TGF-b1 can
be considered as a cytokine preferentially produced by Th17
cells. Th17 cell cytokines perform a variety of effector functions
with actions on both immune and nonimmune cells (Korn et al.,
2009). Likewise, TGF-b1 has pleiotropic effects on both hemato-
poietic and nonhematopoietic cells and plays an important roleA
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Figure 7. T Cell-Produced TGF-b1 Acts in an Autocrine Manner to Pro
Cytokine expression of wild-type (WT) and Tgfb1f/nCd4-cre (KO) CD4+ T cells isola
disease onset, CD4+ T cells were isolated from the CNS, stimulated with PMA an
(A) is one representative plot of nine mice analyzed. The ratios of all WT to KO C
404 Immunity 34, 396–408, March 25, 2011 ª2011 Elsevier Inc.in fibrosis and wound healing (Li et al., 2006b). It is thus plausible
that TGF-b1 production by Th17 cells is important for aiding
tissue repair in the target tissue. The effector function of Th17
cell-expressed TGF-b1 on nonimmune cells warrants further
investigation.
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Immunity
Autocrine TGF-b1 Promotes Th17 Cell Differentiationin models of systemic autoimmunity and graft-versus-host
disease (Lohr et al., 2006; Veldhoen et al., 2006b; Vokaer et al.,
2010). We show here that though the absence of TGF-b1 from
activated CD4+ T cells and Treg cells leads to abrogated Th17
cell generation and resistance to EAE, TGF-b1 produced by
Treg cells alone is not essential for generating encephalitogenic
Th17 cells. Treg cells may promote Th17 cell differentiation
through TGF-b1-independent mechanisms. In support of this
hypothesis, Chen et al. (2011, in this issue) have demonstrated
that requirement of Treg cells for the early polarization of Th17
cells relies on IL-2 consumption and is independent of TGF-b1
production by Treg cells.
We and others have previously shown in a cotransfer model of
colitis that TGF-b1 derived from Treg cells is required for inhibit-
ing Th1 cell differentiation and colitis development (Li et al., 2007;
Powrie et al., 1996). However, we did not observe any signs of
spontaneous colitis in Tgfb1f/n Foxp3-cre mice, nor was there
an increase in colonic Th1 cells. This discrepancy may result
from the difference in colitis models. In the cotransfer model,
we found that TGF-b1 originating from naive T cells contributes
to Th1 cell inhibition as well (Li et al., 2007), implying that
activated T cell-produced TGF-b1 is also required to inhibit
spontaneous Th1 cell differentiation, and colitis development in
an autocrine manner. Indeed our experiments with mixed bone
marrow chimeric mice showing an increased frequency of
IFN-g-producing KO CD4+ T cells support a role for autocrine
TGF-b1 in limiting Th1 cell generation. In addition, it is possible
that redundancy in TGF-b1 production by both Treg cells and
conventional CD4+ T cells results in protection from colitis in
Tgfb1f/n Foxp3-cre mice. Interestingly, the colitis phenotype in
Tgfb1f/n Tnfrsf4-cre mice was less severe than what we previ-
ously observed in Tgfb1f/n Cd4-cre mice (Li et al., 2007). This
suggests that there is compensation by TGF-b1 produced by
other T cell types, such as CD8+ T cells or naive CD4+ T cells,
which may limit Th1 cell differentiation and colitis.
T cell-produced TGF-b1 is required to inhibit the proliferation of
peripheral Treg cells but is dispensable for their maintenance (Li
et al., 2007). The analysis of Treg cells in the peripheral lymphoid
organsofTgfb1f/nFoxp3-cremice showed that TGF-b1produced
by Treg cells is indispensable to limit their expansion. Therefore,
the autocrine action of TGF-b1 is not restricted to Th17 or Th1
cell differentiation but is also a mechanism used by Treg cells to
control Treg cell homeostasis. TGF-b1 is secreted as a latent
protein that requires liberation from the latent complex to be
active (Li and Flavell, 2008). avb8 integrin expressed on dendritic
cells (DCs) is essential for the activation of TGF-b1 involved in
T cell regulation and Th17 cell differentiation (Acharya et al.,
2010; Lacy-Hulbert et al., 2007; Melton et al., 2010; Travis et al.,
2007). DCs interact closely with CD4+ T cells for antigen presen-
tation during T cell priming but they are also crucial for mediating
entry of autoreactive T cells into theCNSduring EAE (Greter et al.,
2005;McMahonetal., 2005). Furthermore, theubiquitousexpres-
sion of the TGF-b receptor suggests that TGF-b1 will be rapidly
consumed by cells in the immediate vicinity of TGF-b1 activation,
thereby limiting its effects on other cells. We can thus speculate
that the predominantly autocrine mode of TGF-b1 regulation of
Treg cells or effector CD4+ T cells results from both its require-
ment for activation by avb8-expressing DCs and its rapid
consumption by the same TGF-b1-producing T cells.In conclusion, we report that activated Th17 cells themselves
are an essential source of TGF-b1, which functions in an
autocrine manner to promote the stability of the Th17 cell
lineage. These findings clarify our understanding of the cellular
mechanisms involved in the control of Th17 cell differentiation
that can be exploited for the immunotherapy of autoimmune
disease.EXPERIMENTAL PROCEDURES
Mice
Mouse genomic DNA of the Tgfb1 gene was isolated from a 129SV BAC library
(genome System). The coding sequence of gfp gene (encoding green fluores-
cent protein) and a stop codon was inserted after the start codon of Tgfb1
gene. We constructed the targeting vector by cloning three genomic frag-
ments into plasmid pEasy-Flox. Linearized targeting vector was transfected
into ES cells (TC1). Homologous recombinants were identified by Southern
blot analysis. Clones carrying the mutated allele of the Tgfb1 gene (TGF-b1-
GFP) were injected into blastocysts and were implanted into foster
mothers. Chimeric mice were bred to C57BL/6 mice, and the F1 generation
was screened for germline transmission of the mutated allele. TGF-b1-GFP
knockin mice were backcrossed to C57BL/6 background for 10 generations
before use in experiments. Mice containing floxed Tgfb1, Cd4-cre, Tnfrsf4-
cre, Foxp3-cre, and Foxp3-RFP alleles were already described (Klinger
et al., 2009; Lee et al., 2001; Li et al., 2007; Rubtsov et al., 2008; Wan and
Flavell, 2005). Rosa26-YFP reporter and Rag1/ mice were obtained from
the Jackson Lab. Treg cell-specific TGF-b1-deficient mice were created by
crossing Tgfb1-floxed mice with the Foxp3-cre transgene. Treg and activated
T cell-specific TGF-b1-deficient mice were created by crossing Tgfb1-floxed
mice with the Tnfrsf4-cre transgene. For both strains of mice, the TGF-b1-
GFP knockin allele was also used as a Tgfb1-null allele to compensate the
deletion of LOC232987 gene in the floxed Tgfb1 allele as previously reported
(Li et al., 2007). TGF-b1-GFP knockin mice were crossed with Foxp3-RFP
mice, which mark Treg cells by red fluorescent protein expression. All mice
were maintained under specific-pathogen-free conditions and animal experi-
mentation was conducted in accordance with institutional guidelines.PCR Typing
For detection of the floxed and deleted Tgfb1 alleles, DNA was isolated from
different cell types and was analyzed by PCR with the following primer set:
50-CTTCCTAACCCCAGAGGTGGA-30, 50-CACATTAAGTCGTGGCTAGGG-30,
and 50-CCCAGGCTAGCCTTGAACTTCT-30. To analyze germline transmission
of the GFP knockin allele the following primers were used: 50-CGCATCCCA
CCTTTGCCGAG-30, 50-GGCGTCAGCACTAGAAGCCA-30, and 50-GCCGTAG
GTCAGGGTGGTCA-30.Flow Cytometry
Fluorescent dye-labeled antibodies against cell surface markers CD4, TCR-b,
CD62L, CD44, CD45.1, and CD45.2 were purchased from eBiosciences.
Spleen and lymph node cells were depleted of erythrocytes by hypotonic lysis.
Cells were incubated with specific antibodies for 20min at 4C in the presence
of 2.4G2 mAb to block FcgR binding. All samples were acquired and analyzed
with LSR II flow cytometer (Becton Dickenson) and FlowJo software (Tree
Star). Intracellular Foxp3 staining was carried out with a kit from eBiosciences.
For intracellular cytokine staining, spleen, lymph node, CNS cells, and IELs
were stimulated with 50 ng/ml phorbol 12-myristate 13-acetate (PMA, Sigma),
1 mM ionomycin (Sigma), and Golgistop (BD Biosciences) for 4 hr. After
stimulation, cells were stained with cell surface marker antibodies, fixed,
and permeabilized with a Cytofix/Cytoperm kit (BD Biosciences) and stained
with IFN-g and IL-17 antibodies.ELISA
To detect TGF-b1 cytokine amounts in the tissue-culture supernatant, latent
TGF-b1 in the culture supernatant was activated by acid treatment and
assayed with antibody pairs from R&D Systems (BAF240 and MAB1835).Immunity 34, 396–408, March 25, 2011 ª2011 Elsevier Inc. 405
Immunity
Autocrine TGF-b1 Promotes Th17 Cell DifferentiationCell Purification and Culture
CD4+ and CD8+ T cells were enriched from spleen and lymph node cells by
positive selection with anti-CD4 and anti-CD8 microbeads (Miltenyi Biotec).
Enriched T cells were further purified with a cell sorter (Becton Dickenson)
by gating on RFP+CD4+ T cells for Treg cell isolation. Sorted and enriched
CD4+Foxp3+, CD4+Foxp3, and CD8+ T cells were cultured at 1 3 106 cells/
well on CD3-coated plates for 24 hr in medium supplemented with nutri-
doma-SP (Roche). Naive CD4+ T cells were enriched from spleen and lymph
nodes of WT mice with CD4+CD62L+ T cell isolation kit (Miltenyi Biotec). For
in vitro T cell differentiation, 1 3 106 naive CD4+ T cells were added to a 24-
well plate coated with 5 mg/ml CD3 antibody in complete medium and supple-
mented with 2 mg/ml CD28 antibody. T cells were differentiated for 3 days with
the following cytokines and antibodies: 50 U/ml IL-2, 10 mg/ml anti-IFN-g
(XMG1.2) and anti-IL-4 (11B11), 10 ng/ml IL-12, 10 ng/ml IL-4, 1 ng/ml
hTGF-b1, 50 ng/ml IL-6, 10 ng/ml IL-1b, and 50 ng/ml IL-23. For detecting
TGF-b1 production, differentiated T cells were counted and resuspended at
the same concentration in medium supplemented with nutridoma-SP (Roche)
in plates coated with CD3 (2 mg/ml) antibody for 24 hr.
EAE Induction and Disease Scoring
Mice were immunized subcutaneously with 50 mg/ml MOG35-55 peptide in
200 ml emulsion of CFA (IFA supplemented with 2.5 mg/ml Mycobacterium
tuberculosis) and were injected on days 0 and 2 with 200 ng/mouse pertussis
toxin (List Biological Laboratories). The scoring system used was as follows: 1,
limp tail; 2, partial hind-limb paralysis; 3, total hind-limb paralysis; 4, hind-limb
paralysis and 75% body paralysis; and 5, complete body paralysis or
moribund.
Isolation of Mononuclear Cells from CNS and Small Intestine
Mononuclear cells from spinal cords, brain stem, and cerebellumwere isolated
as previously described (Li et al., 2007). In brief, mice were perfused with 20 ml
PBS with 2 mM EDTA. Brain stem and cerebellum were dissected and the
spinal cord was flushed out with PBS, cut into pieces, and digested in PBS
supplemented with 10 mg/ml Collagenase D (Roche). The digested CNS
was passed through a 70 mm cell strainer, washed, and resuspended in
38% Percoll solution (Sigma) and pelleted for 20 min at 2000 rpm. Cells
were washed in PBS and used in experiments. For intraepithelial lymphocyte
isolation, the small intestine was dissected and, after removal of Peyer’s
patches, was incubated two times with DMEM supplemented with 10% FBS
and 1 mM DTT for 20 min at 37C on a shaker. Supernatant was passed
through a 70 mm cell strainer, pelleted, and resuspended in 40% Percoll. Cells
were collected from the interface of a 40%:70% Percoll gradient after centri-
fugation at 2500 rpm for 20 min at room temperature. Cells were washed
and used in experiments.
Generation of Bone Marrow Chimeras
Bone marrow cells isolated from 6- to 8-week old CD45.1+ congenic C57BL/6
(WT) mice or CD45.2+ Tgfb1f/n Cd4-cremice were depleted of erythrocytes by
hypotonic lysis and of T cells and antigen-presenting cells by complement-
mediated lysis. A 1:1 mix of WT and Tgfb1f/n Cd4-cre bone marrow cells
were injected i.v. into 6- to 8-week-old sublethally irradiated (600 rad) Rag1/
mice.
Histopathology
Tissues from sacrificed animals were fixed in Safefix II (Protocol) and
embedded in paraffin. 5 mmsections were stained with hematoxylin and eosin.
The histological grading system is as follows: 0, normal colonic crypt architec-
ture with few leukocytes present and plentiful goblet cells; 1, mild inflamma-
tion: slight epithelial hyperplasia and increased numbers of leukocytes in the
mucosa; 2, moderate colitis: pronounced epithelial cell hyperplasia, significant
leukocyte infiltration of the mucosa, and decreased numbers of goblet cells; 3,
severe colitis: marked epithelial hyperplasia with extensive leukocyte infiltra-
tion of the mucosa, submucosa, and tunica muscularis, significant depletion
of goblet cells, occasional ulceration, or crypt abscesses; 4, very severe colitis:
marked epithelial hyperplasia with extensive, dense transmural leukocyte
infiltration from the submucosa through to the serosa, severe depletion of
goblet cells, many crypt abscesses, and severe ulceration.406 Immunity 34, 396–408, March 25, 2011 ª2011 Elsevier Inc.Statistical Analysis
Student’s t test was used to calculate statistical significance for difference in
a particular measurement between groups. A p value of <0.05 was considered
statistically significant.
SUPPLEMENTAL INFORMATION
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